<?xml version="1.0" encoding="UTF-8"?>
<p>We examined the effects of bergenin on GSIS in INS-1E cells. Under normal condition, stimulation with high-glucose (16 mM) resulted in approximately 4-fold increase in insulin secretion relative to low-glucose (2 mM) condition (
 <xref ref-type="fig" rid="pone.0241349.g002">Fig 2B</xref>). We compared the percent of insulin secreted, relative to the insulin content in each well. Two-day treatment of INS-1E cells with a cytokine cocktail reduced GSIS to ˃3.5-fold as compared to the untreated controls (
 <xref ref-type="fig" rid="pone.0241349.g002">Fig 2B</xref>); however, this loss of insulin secretion was significantly suppressed by the addition of 10 μM bergenin to INS-1E cells, with insulin secretion was elevated to ˃80% relative to cytokine-treated cells (
 <xref ref-type="fig" rid="pone.0241349.g002">Fig 2B</xref>). Bergenin also restored GSIS in a dose-dependent manner where insulin stimulation was enhanced to ˃3-fold relative to cytokine-treated cells (
 <xref ref-type="fig" rid="pone.0241349.g002">Fig 2B</xref>).
</p>
